These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3321425)

  • 41. The influence of different insulin regimens on quality of life and metabolic control in insulin-dependent diabetics.
    Tallroth G; Karlson B; Nilsson A; Agardh CD
    Diabetes Res Clin Pract; 1989 Jan; 6(1):37-43. PubMed ID: 2649340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of type 1 diabetes mellitus in children and adolescents].
    Dorchy H
    Rev Prat; 1996 Mar; 46(5):577-86. PubMed ID: 8815524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Short-term and long-term effects on glycosylated hemoglobin after transition from conventional insulin treatment to multiple insulin injection regime in a diabetic outpatient clinic].
    Jensen MK; Ditzel J; Lervang HH; Jensen S; Pedersen JO
    Ugeskr Laeger; 1993 Nov; 155(44):3567-71. PubMed ID: 8236579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of diabetes and quality of life. On possibilities of a more normalized life style using an insulin pen for multi-injection therapy].
    Andresen IL; Haug J; Jervell J; Paus PN
    Tidsskr Nor Laegeforen; 1989 Feb; 109(6):677-80. PubMed ID: 2646754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin-pen: preliminary report on its use for multiple injection regiment in insulin-dependent diabetic patients.
    Kwok CF; Jap TS; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jan; 49(1):12-5. PubMed ID: 1312379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A pen-injector of insulin in young diabetics: freedom and excessive weight gain].
    Dorchy H
    Pediatrie; 1988; 43(8):697-702. PubMed ID: 3065723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The selection of insulin and adjustment of the dosage in diabetic children and adolescents: personal experiences].
    Dorchy H
    Rev Med Brux; 2000 Feb; 21(1):19-27. PubMed ID: 10748684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improvement of the compliance with blood glucose monitoring in young insulin-dependent diabetes mellitus patients by the Sensorlink system.
    Dorchy H; Roggemans MP
    Diabetes Res Clin Pract; 1997 May; 36(2):77-82. PubMed ID: 9229191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Usefulness of short-term usage of real time continuous glucose monitoring system in achieving metabolic control improvement in adolescents with type 1 diabetes].
    Głowińska-Olszewska B; Jabłońska J; Otocka A; Florys B; Jamiołkowska M; Tobiaszewska M; Semeran K; Peczyńska J; Łuczyński W; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2011; 17(4):179-87. PubMed ID: 22248777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy, safety and acceptability of the new pen needle 34G × 3.5 mm: a crossover randomized non-inferiority trial; AGO 02 study.
    De Berardis G; Scardapane M; Lucisano G; Abbruzzese S; Bossi AC; Cipponeri E; D'Angelo P; Fontana L; Lancione R; Marelli G; Sciangula L; Nicolucci A
    Curr Med Res Opin; 2018 Sep; 34(9):1699-1704. PubMed ID: 29924641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preference for a new prefilled insulin pen compared with the original pen.
    Garg S; Bailey T; DeLuzio T; Pollom D
    Curr Med Res Opin; 2011 Dec; 27(12):2323-33. PubMed ID: 21988614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal.
    Del Sindaco P; Ciofetta M; Lalli C; Perriello G; Pampanelli S; Torlone E; Brunetti P; Bolli GB
    Diabet Med; 1998 Jul; 15(7):592-600. PubMed ID: 9686700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
    Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
    Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes.
    Gnanalingham MG; Newland P; Smith CP
    Arch Dis Child; 1998 Jul; 79(1):59-62. PubMed ID: 9771255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.
    Mortensen HB; Robertson KJ; Aanstoot HJ; Danne T; Holl RW; Hougaard P; Atchison JA; Chiarelli F; Daneman D; Dinesen B; Dorchy H; Garandeau P; Greene S; Hoey H; Kaprio EA; Kocova M; Martul P; Matsuura N; Schoenle EJ; Søvik O; Swift PG; Tsou RM; Vanelli M; Aman J
    Diabet Med; 1998 Sep; 15(9):752-9. PubMed ID: 9737804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
    Dorchy H
    Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes.
    Seggelke SA; Hawkins RM; Gibbs J; Rasouli N; Wang CC; Draznin B
    Endocr Pract; 2014 Jun; 20(6):536-9. PubMed ID: 24326004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes.
    Olinder AL; Kernell A; Smide B
    Pediatr Diabetes; 2009 Apr; 10(2):142-8. PubMed ID: 19175898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.